Skip to main content

Advertisement

Log in

Women with Cardiovascular Disease Have Increased Risk of Osteoporotic Fracture

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

This study investigated whether women with cardiovascular disease (CVD) would have an increased risk of fractures as osteoporosis and CVD share many common risk factors. From February 2006 to January 2007, 17,033 women aged ≥50 years (mean 71.8, range 50–106) were recruited by 1,248 primary care practitioners and interviewed by trained nurses. For each woman, 10-year probability of a future major osteoporotic fracture was estimated using the World Health Organization Fracture Risk Assessment Tool (FRAX). The study showed that the 10-year probability of a major osteoporotic fracture was higher for 6,219 CVD women compared to 10,814 non-CVD women after adjustment for age, BMI, current smoking, and alcohol use (adjusted geometric means 14.3 and 13.8%, respectively; P < 0.001). With regard to high risk of fracture (i.e., 10-year probability ≥ 20%), the adjusted odds ratio for CVD was 1.23 (95% CI 1.13–1.35, P < 0.001). However, compared to non-CVD women, CVD women were more likely to report a previous fracture, to have a secondary osteoporosis, and to use glucocorticoids. Among the 4,678 women who were classified as having a high fracture risk, current use rate of bone-related medications (i.e., any one of bisphosphonates, raloxifene, PTH, vitamin D, calcium, or hormone therapy) was 50.2% in the CVD group and 56.9% in the non-CVD group. Women with CVD were at increased risk of fracture partly due to bone-specific risk factors such as history of previous fracture, use of glucocorticoids, and secondary osteoporosis. This risk is not being treated appropriately by primary health physicians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349:1498–1504

    Article  CAS  PubMed  Google Scholar 

  2. Cooper C, Campion G, Melton LJ III (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289

    Article  CAS  PubMed  Google Scholar 

  3. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A (2007) The burden of disease and injury in Australia 2003. Australian Institute of Health and Welfare, Canberra

    Google Scholar 

  4. Osteoporosis consensus statement, Australia (1997) Med J Aust. http://www.mja.com.au/public/guides/osteo/whatis.html

  5. Cumming RG, Nevitt MC, Cummings SR (1997) Epidemiology of hip fractures. Epidemiol Rev 19:244–257

    CAS  PubMed  Google Scholar 

  6. Giardina EG (2000) Heart disease in women. Int J Fertil Womens Med 45:350–357

    CAS  PubMed  Google Scholar 

  7. McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23:1–10

    Article  CAS  PubMed  Google Scholar 

  8. NIAMS-NHLBI Working Group (1999) New evidence connecting cardiovascular disease and osteoporosis. www.nhlbi.nih.gov/meetings/workshops/bnhrtsm.htm

  9. Warburton DE, Nicol CW, Gatto SN, Bredin SS (2007) Cardiovascular disease and osteoporosis: balancing risk management. Vasc Health Risk Manag 3:673–689

    PubMed  Google Scholar 

  10. Hyder JA, Allison MA, Wong N, Papa A, Lang TF, Sirlin C, Gapstur SM, Ouyang P, Carr JJ, Criqui MH (2009) Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol 169:186–194

    Article  PubMed  Google Scholar 

  11. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 68:271–276

    Article  CAS  PubMed  Google Scholar 

  12. Jorgensen L, Singh K, Berntsen GK, Jacobsen BK (2004) A population-based study of the prevalence of abdominal aortic aneurysms in relation to bone mineral density: the Tromso study. Am J Epidemiol 159:945–949

    Article  PubMed  Google Scholar 

  13. Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB (2007) Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int 18:505–512

    Article  CAS  PubMed  Google Scholar 

  14. Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR (1993) Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24:940–946

    CAS  PubMed  Google Scholar 

  15. Von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278

    Article  PubMed  Google Scholar 

  16. Carbone L, Buzkova P, Fink HA, Lee JS, Chen Z, Ahmed A, Parashar S, Robbins JR (2010) Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 31:77–84

    Article  PubMed  Google Scholar 

  17. Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaelsson K (2009) Cardiovascular diseases and risk of hip fracture. JAMA 302:1666–1673

    Article  CAS  PubMed  Google Scholar 

  18. van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA (2008) Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16, 294 patients. Circulation 118:1946–1952

    Article  PubMed  Google Scholar 

  19. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 357:1799–1809

    Article  CAS  PubMed  Google Scholar 

  20. Colon-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S, Delmas P et al (2008) Potential mediators of the reduction in mortality with zoledronic acid after hip fracture. J Bone Miner Res 23:S10 abstract 1030

    Google Scholar 

  21. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397

    Article  CAS  PubMed  Google Scholar 

  22. World Health Organization (2007) Assessment of osteoporosis at the primary health care level. WHO, Geneva. http://www.who.int/chp/topics/rheumatic/en/index.html

  23. Chen JS, Hogan C, Lyubomirsky G, Sambrook PN (2009) Management of osteoporosis in primary care in Australia. Osteoporos Int 20:491–496

    Article  CAS  PubMed  Google Scholar 

  24. Garvan Institute. Fracture risk calculator. http://garvan.org.au/promotions/bone-fracture-risk/calculator. Accessed 2 Mar 2010

  25. Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19:1105–1112

    Article  CAS  PubMed  Google Scholar 

  26. Tanko LB, Bagger YZ, Nielsen SB, Christiansen C (2003) Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 32:8–14

    Article  CAS  PubMed  Google Scholar 

  27. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H (2000) Statin drugs and the risk of fracture. JAMA 284:1921–1922

    Article  PubMed  Google Scholar 

  28. Mundy GR (2001) Statins and their potential for osteoporosis. Bone 29:495–497

    Article  CAS  PubMed  Google Scholar 

  29. Sholter DE, Armstrong PW (2000) Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 16:505–511

    CAS  PubMed  Google Scholar 

  30. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90:859–865

    Article  CAS  PubMed  Google Scholar 

  31. Sambrook PN (2005) How to prevent steroid induced osteoporosis. Ann Rheum Dis 64:176–178

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by a research grant from Osteoporosis Australia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip N. Sambrook.

Additional information

Sambrook and Hogan have served on the advisory board and have received speaker fees from Merck. Lyubomirsky is a director of Merck Sharp & Dohme-Asia Pacific. Chen has stated no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J.S., Hogan, C., Lyubomirsky, G. et al. Women with Cardiovascular Disease Have Increased Risk of Osteoporotic Fracture. Calcif Tissue Int 88, 9–15 (2011). https://doi.org/10.1007/s00223-010-9431-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-010-9431-7

Keywords

Navigation